微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 46.2% | -1.73% | -2.07% | 84/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 47.18% | -1.56% | 0.04% | 81/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 47.16% | -5.56% | 0.32% | 82/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 47.01% | -3.15% | -0.01% | 79/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 47.02% | -1.05% | -1.9% | 81/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 47.93% | -2.61% | -4.03% | 78/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 49.94% | 0.75% | 2.88% | 73/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 48.54% | 3.12% | 2.16% | 81/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 47.52% | -2.36% | -3.44% | 82/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 49.21% | 1.02% | -0.72% | 79/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 49.57% | -1.37% | 5.3% | 75/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 47.07% | -2.67% | -3.27% | 84/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 48.67% | 6.26% | -0.09% | 78/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 48.71% | 5.54% | -3.07% | 78/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 50.26% | 1.46% | 3.91% | 77/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 48.37% | -2.14% | 5.6% | 81/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 45.8% | 2% | -0.77% | 81/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 46.16% | -10.66% | -6.82% | 82/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 49.53% | 2% | 0.22% | 75/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 49.42% | 1.67% | -4.33% | 85/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 51.66% | 2% | 6.27% | 78/142 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 48.61% | 2% | 2% | 90/142 | 60.12% | 正海生物 | 90.78% | 行业排名> |